德国ludwig-Maximilians大学神经免疫学研究博士后岗位
日期：2008-06-05
来源：丁香人才网
InstitutionLudwig-Maximilians University MunichPositionPost-Doc in NeuroimmunologyLocationMunich GermanyDate PostedJune 4th 2008Date ExpiresSeptember 3th 2008Tagspostdoc neuroimmunology neuroscience m ...
Institution
Ludwig-Maximilians University Munich
Position
Post-Doc in Neuroimmunology
Location
Munich, Germany
Date Posted
June 4th 2008
Date Expires
September 3th 2008
Tags
postdoc, neuroimmunology, neuroscience, munich, and germany
Description
Our Research Unit is supported by the Emmy-Noether Excellence Program ofthe German National Science Foundation and affiliated with the Instituteof Clinical Neuroimmunology of the Ludwig-Maximilians University Munichand the Dept. of Neuroimmunology of the Max-Planck-Institute of Neurobiology.
Our main focus is to develop new therapeutic strategies for multiplesclerosis a common neurological disease. In multiple sclerosis immunecells attack brain and spinal cord and damage nerve cells, theirconnections and the myelin sheets that isolate them. Our recent studiesindicate that a particular immune cell type, the macrophage, isprimarily responsible for tissue damage. However, while macrophagesmediate tissue damage in multiple sclerosis, they can in principle alsocontribute to CNS protection and repair (Kerschensteiner et al., 2003).This indicates that depending on the disease context macrophages can bepolarized towards distinct “destructive” or “protective” phenotypes. Theaim of this post-doctoral project is now to use a combination of in vivoimaging and ex vivo gene expression profiling to determine theregulatory factors that drive macrophages towards destruction or protection.
We are looking for hard-working, highly motivated applicants who arefluent in english and have a degree in a relevant field of study(biology, biochemistry, medicine). The start date for this position isnegotiable, but we aim for the fall of 2008. Funding for this project issecured through a grant by the German National Science Foundation.
Contact
If you would like to apply, please submit your letter of intent,curriculum vitae and names of two referees to:
Prof. Dr. Martin Kerschensteiner
Head of the Research Unit Therapy Development
Institute of Clinical Neuroimmunology, Ludwig-Maximilians-UniversityMunich, Marchioninistr. 17, 81377 Munich, Germany.
Email: Martin.Kerschensteiner@med.uni-muenchen.de
Selected recent publications of our group:munich
Misgeld, Kerschensteiner et al., Nature Methods, 4: 559-561 (2007)
Misgeld and Kerschensteiner, Nature Reviews Neuroscience 7:449-463 (2006)
Bareyre, Kerschensteiner et al., Nature Medicine 11:1355-1360 (2005)
Kerschensteiner et al., Nature Medicine 11:572-577 (2005)
Bareyre, Kerschensteiner et al., Nature Neuroscience 7: 269-277 (2004)
Kerschensteiner et al., Journal of Experimental Medicine 200: 158-170 (2004)
Kerschensteiner et al., Annals of Neurology 53:292-304 (2003)
Ludwig-Maximilians University Munich
Position
Post-Doc in Neuroimmunology
Location
Munich, Germany
Date Posted
June 4th 2008
Date Expires
September 3th 2008
Tags
postdoc, neuroimmunology, neuroscience, munich, and germany
Description
Our Research Unit is supported by the Emmy-Noether Excellence Program ofthe German National Science Foundation and affiliated with the Instituteof Clinical Neuroimmunology of the Ludwig-Maximilians University Munichand the Dept. of Neuroimmunology of the Max-Planck-Institute of Neurobiology.
Our main focus is to develop new therapeutic strategies for multiplesclerosis a common neurological disease. In multiple sclerosis immunecells attack brain and spinal cord and damage nerve cells, theirconnections and the myelin sheets that isolate them. Our recent studiesindicate that a particular immune cell type, the macrophage, isprimarily responsible for tissue damage. However, while macrophagesmediate tissue damage in multiple sclerosis, they can in principle alsocontribute to CNS protection and repair (Kerschensteiner et al., 2003).This indicates that depending on the disease context macrophages can bepolarized towards distinct “destructive” or “protective” phenotypes. Theaim of this post-doctoral project is now to use a combination of in vivoimaging and ex vivo gene expression profiling to determine theregulatory factors that drive macrophages towards destruction or protection.
We are looking for hard-working, highly motivated applicants who arefluent in english and have a degree in a relevant field of study(biology, biochemistry, medicine). The start date for this position isnegotiable, but we aim for the fall of 2008. Funding for this project issecured through a grant by the German National Science Foundation.
Contact
If you would like to apply, please submit your letter of intent,curriculum vitae and names of two referees to:
Prof. Dr. Martin Kerschensteiner
Head of the Research Unit Therapy Development
Institute of Clinical Neuroimmunology, Ludwig-Maximilians-UniversityMunich, Marchioninistr. 17, 81377 Munich, Germany.
Email: Martin.Kerschensteiner@med.uni-muenchen.de
Selected recent publications of our group:munich
Misgeld, Kerschensteiner et al., Nature Methods, 4: 559-561 (2007)
Misgeld and Kerschensteiner, Nature Reviews Neuroscience 7:449-463 (2006)
Bareyre, Kerschensteiner et al., Nature Medicine 11:1355-1360 (2005)
Kerschensteiner et al., Nature Medicine 11:572-577 (2005)
Bareyre, Kerschensteiner et al., Nature Neuroscience 7: 269-277 (2004)
Kerschensteiner et al., Journal of Experimental Medicine 200: 158-170 (2004)
Kerschensteiner et al., Annals of Neurology 53:292-304 (2003)
微信扫一扫分享资讯
热门职位
更多 >热门招聘单位
更多 >-
湘潭县人民医院
0个职位正在招聘
-
六盘水长生肾病医院有限公司
0个职位正在招聘
-
宝鸡市金台医院
0个职位正在招聘
-
宁夏爱尔眼科医院有限公司
0个职位正在招聘
-
通用环球北京东里医院
0个职位正在招聘
